A Biomarker-Directed, Multi-Center Phase II/III Study of Ctdna Molecular Response Adaptive Immuno-Chemotherapy in Patients with Non-Small Cell Lung Cancer.
JOURNAL OF CLINICAL ONCOLOGY(2024)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
JOURNAL OF CLINICAL ONCOLOGY(2024)